Penn Transplant Institute

Pancreas Transplant Research and Clinical Trials

Penn's active research and clinical trials provide additional resources for pancreas transplant patients. See below for pancreas and islet transplantation clinical trials conducted at Penn.

Islet transplantation in type 1 diabetes using immunosuppression and strategies to improve long term graft survival
Using anti-B lymphocyte agent rituximab (Rituxan) to improve long-term graft survival
Islet transplantation vs. intensive insulin therapy in patients with type 1 diabetes who have already received a kidney transplant

For more information about clinical trials at the Penn Transplant Institute, see Research & Clinical Trials.